ETFs Recordati

REC

IT0003828271

Name	Weight	AuM	1st Jan change	Investor Rating
FRANKLIN FTSE ITALY ETF - USD	1.52%	0 M€	+12.55%
INDEXIQ FACTORS SUSTAINABLE EUROPE EQUITY UCITS ETF - EUR	0.32%	168 M€	+2.52%
FRANKLIN LIBERTYQ EUROPEAN EQUITY UCITS ETF - EUR	0.29%	0 M€	+11.67%	-
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.24%	1,017 M€	+0.63%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.20%	30 M€	+0.27%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.06%	33 M€	+0.32%	-
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	0.04%	0 M€	-.--%
SIMPLIFY DEVELOPED EX-US PLUS DOWNSIDE CONVEXITY ETF - USD	0.03%	0 M€	-3.35%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	0.02%	33,076 M€	+0.77%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.01%	0 M€	-.--%
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.01%	0 M€	-.--%
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD	0.01%	0 M€	-.--%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	0.01%	349 M€	-0.84%
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.01%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.01%	0 M€	-.--%
RAREVIEW SYSTEMATIC EQUITY ETF - USD	0.01%	54 M€	+1.30%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.01%	578 M€	+1.44%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.00%	49 M€	+1.98%	-
IMGP RBA RESPONSIBLE GLOBAL ALLOCATION ETF - USD	0.00%	0 M€	+0.11%	-

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (65.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (34.3%). Net sales are distributed geographically as follows: Italy (15.2%), Europe (56.4%), America (19%), Asia and Oceania (6.7%) and Africa (2.7%).

Employees

4,455

Sector

Pharmaceuticals

Calendar

2025-02-19 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement and Estimates

income-statement-evolution-chart RECORDATI

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

54.90EUR

Average target price

55.74EUR

Spread / Average Target

+1.53%

Consensus

Profit revisions

Estimate revisions

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Borsa Italiana Other stock markets 11:44:59 2025-01-17 am EST			5-day change	1st Jan Change
54.90 ^EUR	+0.64%		+2.91%	+8.50%

Jan. 17	Recordati and its top investor say no plans for deal with Angelini	RE
Jan. 17	Recordati-Angelini, on the plan interest of sovereign wealth funds	AN